ExploRNA Therapeutics and Łukasiewicz — IChP partner on mRNA cap analog manufacturing

ExploRNA Therapeutics and Łukasiewicz — IChP have announced a strategic partnership to advance Good Manufacturing Practice (GMP) manufacturing of next-generation mRNA cap analogs. The collaboration aims to secure an essential raw material supply for clinical-stage mRNA therapeutics and vaccines.